Creative Diagnostics Launches Aflatoxin Test Reagents to Ensure Food Safety

Creative Diagnostics Launches Serum Plate Agglutination Test for In Vitro Detection of Multiple Pathogens

Creative Diagnostics Announces New AAV Reagent Solutions for Gene Therapy

Creative Diagnostics Announces MDT Services for Measuring Antibacterial Effectiveness

Creative Diagnostics Launches Rapid Robenidine Test Reagents for the Analysis of Anticoccidial Residues

Creative Diagnostics Launches New P53 and Tp53 Antibodies for Cancer Research

Macrophage Migration Inhibitory Factor Reagents for Research Applications

Creative Diagnostics has announced the launch of its new Minimum Bactericidal Concentration (MBC) Assay for antibacterial testing. The new assay is a more accurate and sensitive measure of the effectiveness of antibiotics.

Creative Diagnostics has successfully developed a range of reagents for the analysis of Dapsone in food, including Dapsone Antibodies & Antigens, Dapsone ELISA Kits, and Dapsone Screen Tests.

Creative Diagnostics Launches New Anti-Small Molecule Label Antibodies to Facilitate NALFIA Development

Creative Diagnostics Launches Checkerboard Assay Services

Creative Diagnostics Launches New Azaperone Test Reagents for Research Applications.

Creative Diagnostics has announced a series of new reagent solutions to assist researchers in the bioanalysis of ADCs.

Creative Diagnostics announced the launch of its new Antimicrobial Susceptibility Testing (AST) services.

Creative Diagnostics has introduced its new qPCR Assay to the research community.

Creative Diagnostics has announced the launch of new reagent solutions for herpesvirus research.

Creative Diagnostics has launched a set of highly specific antibodies against FXIIIa/F13A1 for vascular diseases.

Creative Diagnostics has launched its new Single Radial Immunodiffusion Testing services for the biological industry.

Creative Diagnostics recently introduced a series of Viral Replicon Assay services to assist researchers in identifying and studying viruses.

Creative Diagnostics announces the launch of its new line of Calprotectin Reagents to accelerate research in inflammatory diseases.

Creative Diagnostics introduced the Virus Yield Reduction Assay Service to support researchers in evaluating the antiviral activity of compounds.

Creative Diagnostics recently introduced a new line of low endotoxin antibodies to biopharmaceutical research laboratories.